| Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer C Herberts, M Annala, J Sipola, SWS Ng, XE Chen, A Nurminen, ... Nature 608 (7921), 199-208, 2022 | 129 | 2022 |
| The 5-hydroxymethylcytosine landscape of prostate cancer M Sjöström, SG Zhao, S Levy, M Zhang, Y Ning, R Shrestha, A Lundberg, ... Cancer research 82 (21), 3888-3902, 2022 | 44 | 2022 |
| Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer NM Fonseca, C Maurice-Dror, C Herberts, W Tu, W Fan, AJ Murtha, ... Nature Communications 15 (1), 1828, 2024 | 33 | 2024 |
| Early on-treatment changes in circulating tumor DNA fraction and response to enzalutamide or abiraterone in metastatic castration-resistant prostate cancer SH Tolmeijer, E Boerrigter, T Sumiyoshi, EM Kwan, SWS Ng, M Annala, ... Clinical Cancer Research 29 (15), 2835-2844, 2023 | 29 | 2023 |
| Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping EW Warner, K Van der Eecken, AJ Murtha, EM Kwan, C Herberts, J Sipola, ... Nature Cancer 5 (1), 114-130, 2024 | 16 | 2024 |
| Genomic features of lung-recurrent hormone-sensitive prostate cancer NM Fonseca, K Van der Eecken, C Herberts, S Verbeke, SWS Ng, ... JCO precision oncology 6, e2100543, 2022 | 10 | 2022 |
| A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes EJ Ritch, C Herberts, EW Warner, SWS Ng, EM Kwan, JVW Bacon, ... NPJ Precision Oncology 7 (1), 27, 2023 | 7 | 2023 |
| Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer SWS Ng, AW Wyatt Nature Reviews Urology 18 (5), 255-256, 2021 | 6 | 2021 |
| On-treatment plasma ctDNA fraction and treatment outcomes in metastatic castration-resistant prostate cancer. SH Tolmeijer, E Boerrigter, T Sumiyoshi, S Ng, EM Kwan, M Annala, ... Journal of Clinical Oncology 40 (16_suppl), 5051-5051, 2022 | 5 | 2022 |
| Modeling the trajectory of SARS-CoV-2 spike protein evolution in continuous latent space using a neural network and Gaussian process S King, XE Chen, SWS Ng, K Rostin, T Roberts, SV Hahn, JC Schwab, ... bioRxiv, 2021.12. 04.471198, 2021 | 4 | 2021 |
| Circulating tumour DNA fraction as a predictor of treatment efficacy in a randomized phase 2 trial of [177Lu] Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration … EM Kwan, MS Hofman, SW Ng, L Emmett, S Sandhu, JP Buteau, A Iravani, ... J Clin Oncol. 42, 5055, 2024 | 2 | 2024 |
| Forecasting SARS-CoV-2 spike protein evolution from small data by deep learning and regression S King, XE Chen, SWS Ng, K Rostin, SV Hahn, T Roberts, JC Schwab, ... Frontiers in Systems Biology 4, 1284668, 2024 | 1 | 2024 |
| Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer E Warner, K Van der Eecken, AJ Murtha, EM Kwan, SW Ng, XE Chen, ... Cancer Research 82 (12_Supplement), 41-41, 2022 | 1 | 2022 |
| Abstract IA006: Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer AW Wyatt, AJ Murtha, E Warner, K Van der Eecken, EM Kwan, C Herberts, ... Cancer Research 83 (11_Supplement), IA006-IA006, 2023 | | 2023 |
| Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer AW Wyatt, AJ Murtha, E Warner, K Van der Eecken, EM Kwan, C Herberts, ... American-Association-for-Cancer-Research (AACR) Special Conference 83 (11 …, 2023 | | 2023 |
| to refine cancer treatment T Sumiyoshi, EM Kwan, S Ng, M Annala, G Donnellan, C Herberts, ... Circulating tumor DNA measurements, 43, 2023 | | 2023 |
| Young innovators and the bioeconomy XE Chen, S King, SWS Ng, P Salman, JC Schwab, P Sekhon Genomics and the Global Bioeconomy, 83-100, 2023 | | 2023 |
| 4MO Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer AJ Murtha, E Warner, K van der Eecken, E Kwan, C Herberts, J Sipola, ... Annals of Oncology 33, S1384, 2022 | | 2022 |
| Clonal architecture and evolution of treatment-resistant prostate cancer via deep whole-genome ctDNA sequencing C Herberts, M Annala, J Sipola, SW Ng, XE Chen, A Nurminen, ... Cancer Research 82 (12_Supplement), 3625-3625, 2022 | | 2022 |
| Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer N Fonseca, K Van der Eecken, C Herberts, S Verbeke, S Ng, N Lumen, ... Global Congress on Prostate and Bladder Cancer 2021, 2021 | | 2021 |
